Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-17
SponsorChildren's Mercy Hospital Kansas City

About this trial

The goal of this study is to help teens with Prader-Willi Syndrome (PWS) and their families learn practical strategies for managing issues like irritability, meltdowns, and anxiety. The main objective of the study is:

To adapt current Regulating Together materials to create an outpatient group program for emotion dysregulation in Prader-Willi Syndrome (PWS) that will improve psychosocial outcomes for youth with PWS.

Eligibility criteria

Qualifiers

Ages 13-17.5 years

Confirmed genetic diagnosis of Prader-Willi Syndrome

Fluent in spoken English

Adolescent's use of flexible phrase speech or greater

Disqualifiers

Initiation of new psychosocial intervention within 30 days prior to first day of treatment

Presence of physical aggression in the adolescent directed towards a peer outside the home that resulted in injury within 30 days prior to screening

Presence of comorbid major neuropsychiatric illness warranting other treatment approaches

Presence of any major sensory impairment that would limit participating in the material including blindness or uncorrected hearing loss

Trial design

Treatments tested in this trial

  • Regulating Together group therapy

Treatment groups

10 Participants
are divided into 1 treatment group

Sponsors and collaborators

Children's Mercy Hospital Kansas City

Lead sponsor

Foundation for Prader-Willi Research

Collaborator